>The PR suggests LFB will contribute more than money.<
The text you cited is boilerplate, however. I was inquiring about what know-how LFB has with respect to FIX, specifically.
In the FVIIa collaboration between the companies, it was acknowledged that LFB had already done a substantial portion of the preclinical development by the time GTC signed on. There is no similar acknowledgement with respect to the FIX program, at least not yet.
Market Data 
Markets 
AI
